Sweet gene victory around the corner? Therapeutic advances come rolling in
As the UK Government opens its new ‘Catapult’ centre devoted to gene therapy manufacturing, could 2018 be the year of its mainstream commercialisation? BV’s...
The fail of Berlin?
After months of quiet anxiety about trade conditions for the country, the voices of Germany’s business leaders are becoming louder as they believe they...
Indian Summer On The Horizon
Investors had been keeping their distance from India this last 12 months as New Delhi's business hubs looked like being on the brink of...
Glue-shoe syndrome for Brexit: a step forward… or sideways?
An analysis of the latest Brexit developments shows that just beneath the surface of the mud… is more mud. BV’s Jason Agnew reports.
THE Eagles’...
Rio Tinto Paying Dividends
Handsome pay-outs for mining shareholders as strong underlying earnings deliver record interims for investors…
By Darren Parkin
A SURGE in commodity prices and a rush in...
Status symbols in and out of the boardroom
From cufflinks to cars, Blackberries to dog breeds: status symbols are evolving. BV’s RICHARD THOMAS cranes his neck to get a glimpse of the...
Emma’s marvellous medicine
GlaxoSmithKline’s mighty empire faces a new chapter with the retirement of Sir Andrew Witty
A MOTHER-of-four from the gritty industrial town of Barrow-in-Furness will create...
Paul Allen – The Forgotten Man Of Microsoft
When two school friends set up their own software business, one of them didn’t expect it to become one of the most successful companies...
Majid Al Futtaim making tracks across MENA
UAE billionaire announces a raft of fresh investments to revitalise dozens of projects in the region…
By Darren Parkin
WHEN the Majid Al Futtaim Group –...
Rise and rise of the budget supermarket
Aldi looks to replicate its monumental success across Europe by opening hundreds of new stores across America, while its almost identical rival Lidl is...
